RU2007125380A - Сульфанил-замещенные фенилметаноны в качестве ингибиторов переносчика глицина 1 (glyt-1) для лечения неврологических и психоневрологических заболеваний - Google Patents
Сульфанил-замещенные фенилметаноны в качестве ингибиторов переносчика глицина 1 (glyt-1) для лечения неврологических и психоневрологических заболеваний Download PDFInfo
- Publication number
- RU2007125380A RU2007125380A RU2007125380/04A RU2007125380A RU2007125380A RU 2007125380 A RU2007125380 A RU 2007125380A RU 2007125380/04 A RU2007125380/04 A RU 2007125380/04A RU 2007125380 A RU2007125380 A RU 2007125380A RU 2007125380 A RU2007125380 A RU 2007125380A
- Authority
- RU
- Russia
- Prior art keywords
- lower alkyl
- halogen
- phenyl
- methanesulfonyl
- piperazin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/10—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
- C07D295/104—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D295/182—Radicals derived from carboxylic acids
- C07D295/192—Radicals derived from carboxylic acids from aromatic carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Claims (12)
1. Соединения общей формулы
где R1 представляет собой низший алкил или низший алкил, замещенный галогеном;
R2 представляет собой -S(O)2-низший алкил, -S(О)2NH-низший алкил, NO2 или CN;
R3 представляет собой галоген, CN, низший алкил, низший алкил, замещенный галогеном, NO2, -С(O)-низший алкил или S(O)2-низший алкил;
Х/Х1 независимо друг от друга представляют собой CR4 или N;
R4 представляет собой водород или галоген;
n представляет собой 0, 1 или 2;
и их фармацевтически приемлемые кислотно-аддитивные соли.
2. Соединения формулы I-A по п.1
где R1 представляет собой низший алкил или низший алкил, замещенный галогеном;
R2 представляет собой -S(O)2-низший алкил, -S(O)2NH-низший алкил, NO2 или CN;
R3 представляет собой галоген, CN, низший алкил, низший алкил, замещенный галогеном, NO2, -С(O)-низший алкил или S(O)2-низший алкил;
R4 представляет собой водород или галоген;
n представляет собой 0, 1 или 2;
и их фармацевтически приемлемые кислотно-аддитивные соли.
3. Соединения формулы I-Б по п.1
где R1 представляет собой низший алкил или низший алкил, замещенный галогеном;
R2 представляет собой -S(O)2-низший алкил, -S(O)2NH-низший алкил, NO2 или CN;
R3 представляет собой галоген, CN, низший алкил, низший алкил, замещенный галогеном, NO2, -С(O)-низший алкил или S(O)2-низший алкил;
n представляет собой 0, 1 или 2;
и их фармацевтически приемлемые кислотно-аддитивные соли.
4. Соединения формулы I-B по п.1
где R1 представляет собой низший алкил или низший алкил, замещенный галогеном;
R2 представляет собой -S(O)2-низший алкил, -S(О)2NH-низший алкил, NO2 или CN;
R3 представляет собой галоген, CN, низший алкил, низший алкил, замещенный галогеном, NO2, -С(O)-низший алкил или S(O)2-низший алкил;
R4 представляет собой водород или галоген;
n представляет собой 0, 1 или 2;
и их фармацевтически приемлемые кислотно-аддитивные соли.
5. Соединения формулы I по п.1, где R1 представляет собой низший алкил.
6. Соединения формулы I по п.5, которые представляют собой
[4-(3-фтор-5-трифторметил-пиридин-2-ил)-пиперазин-1-ил]-(2-изопропилсульфанил-5-метансульфонил-фенил)-метанон,
[4-(2-фтор-4-метансульфонил-фенил)-пиперазин-1-ил]-(2-изопропилсульфанил-5-метансульфонил-фенил)-метанон,
(2-этилсульфанил-5-метансульфонил-фенил)-[4-(3-фтор-5-трифторметил-пиридин-2-ил)-пиперазин-1-ил]-метанон,
[4-(2-фтор-4-метансульфонил-фенил)-пиперазин-1-ил]-(2-изобутилсульфанил-5-метансульфонил-фенил)-метанон,
1-{3-фтор-4-[4-(2-изопропилсульфанил-5-метансульфонил-бензоил)-пиперазин-1-ил]-фенил}-этанон,
[4-(2-хлор-4-нитро-фенил)-пиперазин-1-ил]-(2-изопропилсульфанил-5-метансульфонил-фенил)-метанон,
4-изопропилсульфанил-N-метил-3-[4-(4-трифторметил-фенил)-пиперазин-1-карбонил]-бензолсульфонамид или
(2-изопропилсульфанил-5-нитро-фенил)-[4-(4-трифторметил-фенил)-пиперазин-1-ил]-метанон.
7. Соединения формулы I по п.1, где R1 представляет собой низший алкил, замещенный галогеном.
8. Соединения формулы I по п.7, которые представляют собой
[4-(3-фтор-5-трифторметил-пиридин-2-ил)-пиперазин-1-ил]-[5-метансульфонил-2-(2,2,2-трифтор-этилсульфанил)-фенил]-метанон или
[4-(2-фтор-4-метансульфонил-фенил)-пиперазин-1-ил]-[5-метансульфонил-2-(2,2,2-трифтор-этилсульфанил)-фенил]-метанон.
9. Лекарство, содержащее одно или более чем одно соединение по п.1 и фармацевтически приемлемые эксципиенты.
10. Лекарство по п.9 для лечения заболеваний, относящихся к ингибитору обратного захвата глицина.
11. Лекарство по п.10, где заболевания представляют собой психоз, боль, нейродегенеративную дисфункцию памяти и обучения, шизофрению, слабоумие и синдромы дефицита внимания или болезнь Альцгеймера.
12. Применение соединения по п.1 для изготовления лекарств для лечения психоза, боли, нейродегенеративной дисфункции памяти и обучения, шизофрении, слабоумия и синдромов дефицита внимания или болезни Альцгеймера.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05100066.9 | 2005-01-06 | ||
EP05100066 | 2005-01-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
RU2007125380A true RU2007125380A (ru) | 2009-02-20 |
Family
ID=35976714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2007125380/04A RU2007125380A (ru) | 2005-01-06 | 2005-12-28 | Сульфанил-замещенные фенилметаноны в качестве ингибиторов переносчика глицина 1 (glyt-1) для лечения неврологических и психоневрологических заболеваний |
Country Status (16)
Country | Link |
---|---|
US (2) | US20060149062A1 (ru) |
EP (1) | EP1836178A1 (ru) |
JP (1) | JP2008526795A (ru) |
KR (1) | KR20070094955A (ru) |
CN (1) | CN101356163A (ru) |
AR (1) | AR053659A1 (ru) |
AU (1) | AU2005324023A1 (ru) |
BR (1) | BRPI0519744A2 (ru) |
CA (1) | CA2593453A1 (ru) |
IL (1) | IL184355A0 (ru) |
MX (1) | MX2007008190A (ru) |
NO (1) | NO20073330L (ru) |
RU (1) | RU2007125380A (ru) |
TW (1) | TW200635911A (ru) |
WO (1) | WO2006072435A1 (ru) |
ZA (1) | ZA200705469B (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2131843B1 (en) * | 2007-03-05 | 2011-11-09 | F. Hoffmann-La Roche AG | Process for the synthesis of glyt-1 inhibitors |
MX2011003312A (es) | 2008-10-09 | 2011-04-26 | Hoffmann La Roche | Derivados de pirrolidina n-bencilo. |
US8153653B2 (en) * | 2010-06-22 | 2012-04-10 | Hoffmann-La Roche Inc. | Amido-tropane derivatives |
US9012489B2 (en) * | 2011-08-03 | 2015-04-21 | Boehringer Ingelheim International Gmbh | Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament |
CN103254127B (zh) * | 2013-05-28 | 2015-08-19 | 北京哈三联科技有限责任公司 | 甘氨酸重摄取抑制剂及其应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2423847A1 (de) * | 1973-05-28 | 1975-01-02 | Ciba Geigy Ag | Neue sulfamoylbenzoesaeureamide |
DE2611705A1 (de) * | 1976-03-18 | 1977-09-22 | Josef Dipl Chem Dr Rer N Klosa | N-5-(nitrofurfuryliden-)-1-amino- hydantoin enthaltende kristalloesungsmittel |
CA2322164A1 (en) * | 1998-03-06 | 1999-09-10 | Ludo Edmond Josephine Kennis | Glycine transport inhibitors |
WO2001081308A2 (en) * | 2000-04-20 | 2001-11-01 | Nps Allelix Corp. | Aminopiperidines for use as glyt-1 inhibitors |
JP2006512404A (ja) * | 2002-10-22 | 2006-04-13 | グラクソ グループ リミテッド | H3受容体リガンドとしてのアリールオキシアルキルアミン誘導体 |
EA009986B1 (ru) * | 2003-08-11 | 2008-04-28 | Ф. Хоффманн-Ля Рош Аг | Пиперазин с or-замещенной фенильной группой и его применение в качестве ингибиторов glyt1 |
NZ545613A (en) * | 2003-09-09 | 2009-11-27 | Hoffmann La Roche | 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
NZ545454A (en) * | 2003-09-09 | 2009-11-27 | Hoffmann La Roche | 1-(2-amino-benzoyl)-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
-
2005
- 2005-12-28 EP EP05823987A patent/EP1836178A1/en not_active Withdrawn
- 2005-12-28 BR BRPI0519744-9A patent/BRPI0519744A2/pt not_active IP Right Cessation
- 2005-12-28 AU AU2005324023A patent/AU2005324023A1/en not_active Abandoned
- 2005-12-28 MX MX2007008190A patent/MX2007008190A/es not_active Application Discontinuation
- 2005-12-28 WO PCT/EP2005/014081 patent/WO2006072435A1/en active Search and Examination
- 2005-12-28 CN CNA200580048977XA patent/CN101356163A/zh active Pending
- 2005-12-28 KR KR1020077017952A patent/KR20070094955A/ko active IP Right Grant
- 2005-12-28 CA CA002593453A patent/CA2593453A1/en not_active Abandoned
- 2005-12-28 RU RU2007125380/04A patent/RU2007125380A/ru not_active Application Discontinuation
- 2005-12-28 JP JP2007549823A patent/JP2008526795A/ja active Pending
-
2006
- 2006-01-03 US US11/324,991 patent/US20060149062A1/en not_active Abandoned
- 2006-01-03 TW TW095100182A patent/TW200635911A/zh unknown
- 2006-01-04 AR ARP060100022A patent/AR053659A1/es unknown
-
2007
- 2007-06-29 NO NO20073330A patent/NO20073330L/no not_active Application Discontinuation
- 2007-07-02 IL IL184355A patent/IL184355A0/en unknown
- 2007-07-04 ZA ZA200705469A patent/ZA200705469B/xx unknown
-
2008
- 2008-07-16 US US12/173,886 patent/US20080287455A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CN101356163A (zh) | 2009-01-28 |
TW200635911A (en) | 2006-10-16 |
MX2007008190A (es) | 2007-08-07 |
IL184355A0 (en) | 2007-10-31 |
KR20070094955A (ko) | 2007-09-27 |
AU2005324023A1 (en) | 2006-07-13 |
WO2006072435A1 (en) | 2006-07-13 |
EP1836178A1 (en) | 2007-09-26 |
AR053659A1 (es) | 2007-05-16 |
ZA200705469B (en) | 2008-11-26 |
US20060149062A1 (en) | 2006-07-06 |
BRPI0519744A2 (pt) | 2009-03-10 |
JP2008526795A (ja) | 2008-07-24 |
NO20073330L (no) | 2007-07-20 |
US20080287455A1 (en) | 2008-11-20 |
CA2593453A1 (en) | 2006-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2346945C2 (ru) | Производные n-гетероциклилметилбензамидов, их получение и их применение в терапии | |
BRPI0415833A (pt) | derivados de triaza-espiropiperidina para uso como inibidores de glyt-1 no tratamento de distúrbios neurológicos e neuropsiquiátricos | |
FI105915B (fi) | Menetelmä valmistaa 1-[(4-kloorifenyyli)fenyylimetyyli]-piperatsiinin enantiomeereja | |
BRPI0519794A2 (pt) | derivados de [4-(heteroaril)piperazin-1-il]-(fenil 2,5-substituìdo)metanona como inibidores de transportador de glicina 1 (glyt-1) para o tratamento de distúrbios neurológicos e neuropsiquiátricos | |
EA200700756A1 (ru) | Пиримидоны | |
MX2007006896A (es) | Fenil-metanonas bi- y triciclicas sustituidas como inhibidores del transportador 1 de glicina (glyt-1) para el tratamiento de la enfermedad de alzheimer. | |
MX2007008279A (es) | Compuestos de arilamina sustituidos y su uso como moduladores de la 5-ht6. | |
RU2007120209A (ru) | Производные фенил-пиперазин метанона | |
DK645689D0 (da) | Nye piperazinderivater | |
TW200505907A (en) | Piperidine-benzenesulfonamide derivatives | |
KR102487051B1 (ko) | 아미노카보닐카바메이트 화합물 | |
JP2002504484A (ja) | 新規化合物 | |
HUP0103988A2 (en) | New d3-dopamine receptor selective piperazine and piperidine compounds, process for their preparation, their and pharmaceutical compositions containing them | |
EA200501516A1 (ru) | Производные 2,3,6-тризамещённого-4-пиримидона | |
RU2007125380A (ru) | Сульфанил-замещенные фенилметаноны в качестве ингибиторов переносчика глицина 1 (glyt-1) для лечения неврологических и психоневрологических заболеваний | |
UA90483C2 (ru) | Производные n-(1н-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии | |
CY1110450T1 (el) | Χρησιμοποιηση ενος παραγωγου αλογονιδιου υδροξιμικου οξεος στη θεραπευτικη αγωγη νευροεκφυλιστικων νοσων | |
JP2018517693A (ja) | 選択的ヒストンデアセチラーゼ阻害剤としてのヘテロ環状アルキル誘導体化合物及びこれを含有する薬剤学的組成物 | |
PT1707564E (pt) | ''derivados de indanil-piperazina, o processo para a sua preparação, e composições farmacêuticas que os contenha'' | |
Shinde et al. | Synthesis and antimicrobial activity of 2‐(4‐(benzo [d] thiazol‐5‐ylsulfonyl) piperazine‐1‐yl)‐N‐substituted acetamide derivatives | |
ES2550959T3 (es) | Compuestos antineoplásicos y composiciones farmacéuticas de los mismos | |
JP5486008B2 (ja) | 1‐ブチル‐2‐ヒドロキシアラルキルピペラジン誘導体およびその抗鬱剤としての使用 | |
RU2008148165A (ru) | Замещенные производные фенилметанона | |
JP2018536652A5 (ru) | ||
FI60863C (fi) | Foerfarande foer framstaellning av nya bentshydryloxialkylaminderivat med foerlaengd antihistamineffekt |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20100504 |